Role of Donepezil in Autism: Its Conduciveness in Psychopharmacotherapy
Case Reports in Psychiatry · 2011
DOI: 10.1155/2011/563204 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Psychiatry, 2011. Verfasst von Rohit Kant Srivastava und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Rohilkhand Medical College, Bareilly, Uttar Pradesh 243006, India. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
A woman consulted psychiatric Out-Patient Department (OPD) for her 5-year and 2-month-old son presenting with typical autistic symptoms like social, behavioural, and communicational ineptitudeness. Subsequent treatment with Donepezil resulted in marked improvement in the aforementioned symptomatology. Recent studies in autistic child have shown diminished acetylcholine and nicotinic receptor activity, thus an acetylcholinergic enhancer, Donepezil, likely accounts for improvement in autistic symptoms. Evidently, the case report consolidates Donepezil role as a potentially useful agent in the treatment of cognitive and behavioural symptoms observed in this disorder.
Autor:innen und Institutionen
- Department of Psychiatry, Rohilkhand Medical College, Bareilly, Uttar Pradesh 243006, India.
Zitieren
APA
Srivastava, R. K., Agarwal, M., & Pundhir, A. (2011). Role of Donepezil in Autism: Its Conduciveness in Psychopharmacotherapy. Case Reports in Psychiatry. https://doi.org/10.1155/2011/563204
Vancouver
Srivastava RK, Agarwal M, Pundhir A. Role of Donepezil in Autism: Its Conduciveness in Psychopharmacotherapy. Case Reports in Psychiatry. 2011. doi:10.1155/2011/563204
BibTeX
@article{Srivastava2011,
author = {Srivastava, Rohit Kant and Agarwal, Medhavi and Pundhir, Ashish},
title = {Role of Donepezil in Autism: Its Conduciveness in Psychopharmacotherapy},
journal = {Case Reports in Psychiatry},
year = {2011},
doi = {10.1155/2011/563204}
}
EUVIMED